CAPR vs XLP
Capricor Therapeutics Inc (CAPR) versus XLP (XLP) — a side-by-side from cached financials, not a winner call.
Capricor Therapeutics Inc (CAPR) is a biotechnology company listed on NASDAQ.
XLP (XLP) common stock.
Latest reported CAPR revenue for 2025-12-31 was $0. Net income was -$105.0M. CAPR currently screens at market cap $1.62B.
XLP does not have a complete income-statement cache yet.
CAPR currently screens at market cap $1.62B. XLP currently screens at market cap $0.
Not investment advice. Open the CAPR and XLP stock pages for the full models.
Not investment advice.